Promising new treatment schedule for gefitinib responders after severe hepatotoxicity with daily administration

MeSH terms

• Adenocarcinoma / drug therapy
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Carcinoma, Non-Small-Cell Lung / drug therapy
• Chemical and Drug Induced Liver Injury*
• Drug Administration Schedule
• Female
• Gefitinib
• Humans
• Liver / drug effects
• Liver / physiology
• Lung Neoplasms / drug therapy
• Middle Aged
• Quinazolines / administration & dosage
• Quinazolines / adverse effects*
• Quinazolines / therapeutic use